# Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia

**Authors:** Yu-Han Wang, Chung-Wei Lin, Chiung-Wei Huang

PMC · DOI: 10.3390/biomedicines12092085 · 2024-09-12

## TL;DR

This paper reviews whether omega-3 fatty acids can help treat loss of smell caused by COVID-19, but finds inconsistent evidence and calls for more research.

## Contribution

The paper highlights the need for rigorous, large-scale studies to assess the therapeutic potential of omega-3 PUFAs for olfactory dysfunction.

## Key findings

- A placebo-controlled trial found no significant effect of omega-3 PUFA supplementation on olfactory recovery.
- Existing research has limitations like small sample sizes and lack of placebo controls.
- More studies are needed to explore the role of PUFAs in managing viral infections and sensory recovery.

## Abstract

Some individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) experience anosmia, or loss of smell. Although the prevalence of anosmia has decreased with the emergence of the Omicron variant, it remains a significant concern. This review examines the potential role of polyunsaturated fatty acids (PUFAs), particularly omega-3 PUFAs, in treating COVID-19-induced anosmia by focusing on the underlying mechanisms of the condition. Omega-3 PUFAs are known for their anti-inflammatory, neuroprotective, and neurotransmission-enhancing properties, which could potentially aid in olfactory recovery. However, study findings are inconsistent. For instance, a placebo-controlled randomized clinical trial found no significant effect of omega-3 PUFA supplementation on olfactory recovery in patients with COVID-19-induced anosmia. These mixed results highlight the limitations of existing research, including small sample sizes, lack of placebo controls, short follow-up periods, and combined treatments. Therefore, more rigorous, large-scale studies are urgently needed to definitively assess the therapeutic potential of omega-3 PUFAs for olfactory dysfunction. Further research is also crucial to explore the broader role of PUFAs in managing viral infections and promoting sensory recovery.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096), anosmia (MONDO:0010528)

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249), loss of smell (MESH:D000086582), Anosmia (MESH:D000857), viral infections (MESH:D014777), COVID-19 (MESH:D000086382)
- **Chemicals:** Omega-3 PUFAs (-), PUFAs (MESH:D005231)
- **Species:** Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11428228/full.md

---
Source: https://tomesphere.com/paper/PMC11428228